MedPath

Whole Body Washing With Chlorhexidine for the Eradication of MRSA

Phase 2
Completed
Conditions
MRSA-Colonization
Registration Number
NCT00266448
Lead Sponsor
Heidelberg University
Brief Summary

The purpose of this study is to determine whether whole body washing with chlorhexidine in combination with mupirocine nasal ointment is effective in the eradication of meticillin-resistant Staphylococcus aureus (MRSA).

Detailed Description

The number and rate of infections due to meticillin-resistant Staphylococcus aureus (MRSA)is increasing world wide. Patients who are colonized with MRSA are the main source for further distribution. In addition colonization with MRSA is a precondition for infection.

Whole body washing with antiseptic solutions as part of eradication strategies for MRSA has been widely used. However, there is insufficient evidence to support use of topical antimicrobial therapy for eradicating of MRSA because treatment with antiseptic solution has never been compared to placebo.

Comparison: The efficacy of whole body washing in the control of MRSA was studied in a randomized, placebo-controlled, double-blinded clinical trial. The study treatment consisted of five days of whole body washing either with 4% chlorhexidine solution (verum) or with placebo. All patients received mupirocin nasal ointment and chlorhexidine mouth rinse. The outcome was evaluated 3, 4, 5, 9 and 30 days after treatment by swabs taken from several body site.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • persons who are colonized with MRSA, i.e. one or more cultures from any body site yielded MRSA
Exclusion Criteria
  • ongoing systemic or local antimicrobial treatment directed against MRSA
  • hypersensitivity to mupirocin or chlorhexidine
  • pregnancy
  • previous enrolment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
efficacy of a whole body treatment with chlorhexidine in eradicating overall MRSA carriage
Secondary Outcome Measures
NameTimeMethod
development of MRSA infection
tolerance to the antiseptic whole body treatment

Trial Locations

Locations (1)

University Hospital Heidelberg

🇩🇪

Heidelberg, Germany

© Copyright 2025. All Rights Reserved by MedPath